Filing Details

Accession Number:
0001209191-20-031000
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-20 18:07:15
Reporting Period:
2020-05-18
Accepted Time:
2020-05-20 18:07:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1564824 Allakos Inc. ALLK Pharmaceutical Preparations (2834) 454798831
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674884 A Peter Hudson One Embarcadero Center
Suite 3700
San Francisco CA 94111
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-18 4,549 $71.13 6,989 No 4 S Indirect By Hudson Capital LLC
Common Stock Disposition 2020-05-18 6,989 $72.33 0 No 4 S Indirect By Hudson Capital LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Hudson Capital LLC
No 4 S Indirect By Hudson Capital LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,557,377 Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.72 - $71.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  2. These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 - $72.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  4. These shares are directly held by Alta Partners NextGen Fund I L.P. ("APNG I"). Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein.